Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2005

Patents 101

George B. Stefano, J. Patrick Finn III

Med Sci Monit 2005; 11(12): ED9-10 :: ID: 438814

Abstract

The following discussion provides some general points regarding patent rights and the requirements for obtaining a patent. A patent provides its owner with certain rights to the invention that is recited in the “claims” of the patent. In the United States, those rights include the right to exclude others from making, using, importing, offering for sale, and selling the claimed invention. A patent does not provide its owner with the right to do these activities but rather provides its owner with the right to exclude others from doing them. Owning a patent on an invention does not ensure that you do not infringe some other patent. For example, it is possible for a fi rst inventor to patent compound X, and a second inventor to later patent the use of compound X to treat a particular disease. In this case, the second inventor’s use of compound X would be infringing the fi rst inventor’s patent to compound X. In the United States, the United States Patent and Trademark Offi ce issues patents, which can be in force for up to 20 years from the patent’s earliest claimed priority date. This means that a patent that claims priority to an earlier fi led patent application will expire 20 years from the fi ling date of that earlier patent application. You may also fi le a “provisional” patent application and follow it with a “real” utility application within a year, without starting the 20-year clock until the later fi ling. Other countries calculate patent term in a similar manner. In some cases, a patent may expire before the 20 years. For example, a patent owner may have been required to disclaim a terminal portion of a patent’s term to overcome an examiner’s rejection raised during examination. A review of the issued patent and its fi le history typically reveals
the presence of any fi led terminal disclaimers of patent term. In addition, failure to pay post-issuance
maintenance or annuity fees can lead to a patent expiring prior to the date 20 years from the
earliest claimed priority date.

Keywords: United States, Patents as Topic - legislation & jurisprudence

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750